| Nov 17, 2025 |
Nov 19, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,500
|
-1.38%
|
✓
|
$272.7K |
| Oct 17, 2025 |
Oct 21, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,500
|
-1.37%
|
✓
|
$266.7K |
| Sep 26, 2025 |
Sep 30, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-3,700
|
-0.40%
|
✓
|
$74.2K |
| Sep 23, 2025 |
Sep 25, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-2,800
|
-0.30%
|
✓
|
$56.1K |
| Sep 17, 2025 |
Sep 19, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-6,000
|
-0.65%
|
✓
|
$115.7K |
| Aug 20, 2025 |
Aug 21, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
53.8
|
-1,517
|
-0.16%
|
✓
|
$30.3K |
| Aug 18, 2025 |
Aug 20, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-10,983
|
-1.17%
|
✓
|
$219.9K |
| Jul 17, 2025 |
Jul 21, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,500
|
-1.31%
|
✓
|
$281.5K |
| Jun 17, 2025 |
Jun 18, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,500
|
-1.29%
|
✓
|
$277.3K |
| Jun 3, 2025 |
Jun 5, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-7,500
|
-0.77%
|
✓
|
$150.4K |
| May 19, 2025 |
May 21, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-5,000
|
-0.51%
|
✓
|
$82.5K |
| May 1, 2025 |
May 5, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-7,500
|
-0.76%
|
✓
|
$150.4K |
| Apr 17, 2025 |
Apr 21, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-5,000
|
-0.50%
|
✓
|
$82.1K |
| Mar 17, 2025 |
Mar 19, 2025 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,500
|
-1.25%
|
✓
|
$260.3K |
| Oct 18, 2024 |
Oct 22, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
55.0
|
-924
|
-0.09%
|
✓
|
$27.7K |
| Oct 8, 2024 |
Oct 10, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
38.8
|
-29,977
|
-2.90%
|
✓
|
$841.3K |
| Oct 4, 2024 |
Oct 8, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-14,936
|
-1.42%
|
✓
|
$410.9K |
| Oct 1, 2024 |
Oct 3, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
55.0
|
-526
|
-0.05%
|
✓
|
$14.5K |
| Aug 26, 2024 |
Aug 28, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,000
|
-1.13%
|
✓
|
$274.7K |
| Jul 31, 2024 |
Aug 2, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
50.0
|
-2,270
|
-0.21%
|
✓
|
$62.6K |
| Jul 25, 2024 |
Jul 29, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,000
|
-1.12%
|
✓
|
$299.1K |
| Jun 25, 2024 |
Jun 27, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-12,000
|
-1.10%
|
✓
|
$259.9K |
| May 28, 2024 |
May 30, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-12,000
|
-0.94%
|
✓
|
$278.2K |
| Apr 25, 2024 |
Apr 29, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-12,000
|
-0.94%
|
✓
|
$202.7K |
| Apr 11, 2024 |
Apr 15, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-47,709
|
-3.64%
|
✓
|
$1.2M |
| Mar 25, 2024 |
Mar 27, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-12,000
|
-0.94%
|
✓
|
$210.7K |
| Feb 26, 2024 |
Feb 28, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-12,000
|
-0.94%
|
✓
|
$202.7K |
| Jan 25, 2024 |
Jan 29, 2024 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-12,000
|
-0.94%
|
✓
|
$188.2K |
| Dec 26, 2023 |
Dec 28, 2023 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-12,000
|
-0.94%
|
✓
|
$175.7K |
| Dec 21, 2023 |
Dec 26, 2023 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-8,195
|
-0.64%
|
✓
|
$106.9K |
| Dec 20, 2023 |
Dec 21, 2023 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-7,779
|
-0.61%
|
✓
|
$101.2K |
| Nov 3, 2023 |
Nov 6, 2023 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-8,026
|
-0.63%
|
✓
|
$105K |
| Sep 25, 2023 |
Sep 26, 2023 |
Enliven Therapeutics, Inc.
|
CEO |
Sell |
47.5
|
-12,000
|
-0.94%
|
✓
|
$165.7K |